A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer
Tekijät: Powles T, Paterson S, Kanis JA, McCloskey E, Ashley S, Tidy A, Rosenqvist K, Smith I, Ottestad L, Legault S, Pajunen M, Nevantaus A, Mannisto E, Suovuori A, Atula S, Nevalainen J, Pylkkanen L
Kustantaja: LIPPINCOTT WILLIAMS & WILKINS
Julkaisuvuosi: 2002
Lehti:Journal of Clinical Oncology
Tietokannassa oleva lehden nimiJOURNAL OF CLINICAL ONCOLOGY
Lehden akronyymi: J CLIN ONCOL
Vuosikerta: 20
Numero: 15
Aloitussivu: 3219
Lopetussivu: 3224
Sivujen määrä: 6
ISSN: 0732-183X
DOI: https://doi.org/10.1200/JCO.2002.11.080
Tiivistelmä
Conclusion: Clodronate, given to patients with primary operable breast cancer, may reduce the occurrence of bone metastases, although this reduction was only significant during this medication period. There was a significant reduction in mortality. (C) 2002 by American Society of Clinical Oncology.
Conclusion: Clodronate, given to patients with primary operable breast cancer, may reduce the occurrence of bone metastases, although this reduction was only significant during this medication period. There was a significant reduction in mortality. (C) 2002 by American Society of Clinical Oncology.
Turun yliopiston Tutkimustietojärjestelmän portaali